▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Alkermes Q4 22 Earnings Conference Call At 8:00 AM ET

By RTTNews Staff Writer ✉ | Published: 2/16/2023 6:02 AM ET

Alkermes plc. (ALKS) will host a conference call at 8:00 AM ET on February 16, 2023, to discuss Q4 22 earnings results.

To access the live webcast, log on to http://www.alkermes.com

To listen to the call, dial +1 877 407 2988 (US) or +1 201 389 0923 (International).

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In June 2023

Biotech Stocks Facing FDA Decision In June 2023

Biotech Stocks Facing FDA Decision In April 2023

Biotech Stocks Facing FDA Decision In April 2023

Biotech Stocks Facing FDA Decision In March 2023

Biotech Stocks Facing FDA Decision In March 2023

Latest Updates on COVID-19

FDA Approves Pfizer's COVID-19 Pill Paxlovid

US Revokes Covid Vaccination Requirement For International Air Travel

SD Biosensor Recalls Certain COVID-19 At-Home Tests Distributed By Roche

Read More

COVID-19: Drugs in Development

RELATED NEWS

Alkermes Raises FY23 Guidance With Final Award In Johnson & Johnson Unit Arbitration

Alkermes Q1 Adj. Profit Declines; Reiterates 2023 Financial Expectations

Alkermes plc Q1 Earnings Summary

Alkermes Receives Second Interim Award In Janssen Pharmaceutica Arbitration

Follow RTT

Editor's Pick
Most Read
Most Emailed

Apple Unveils Vision Pro Headset, IOS 17, 15-inch MacBook Air And More

Domino's Offers 50% Off Online Deal Through June 11

Frozen RTE Beef Chili Products Supplied Through NSLP Recalled

Boeing, NASA Further Delay Starliner Crew Flight Launch

Chervon Recalls EGO Power+ Cordless Brushless Hedge Trimmers

E.N.A. Meat Packing Recalls Frozen, Raw Lamb Products

Macy's, Dollar General Q1 Profits Decline

FDA Warns Retailers Against Illegal Sales Of Disposable E-cigarettes

Tillamook Recalls Certain Waffle Cone Swirl Ice Cream Packaged In Chocolate Peanut Butter Carton

Mattel Unveils New Barbie The Movie Collection

Rudolph's OnYums Onion Flavored Rings Sold At Dollar Tree Recalled

Carvana Up 12%; Gets 'notable S&P Global Ratings Upgrades"

Dechra Pharma Agrees To Be Acquired By EQT's Freya Bidco For 3,875p/share In Cash

AstraZeneca Reports Positive Results From Interim Analysis Of DESTINY-PanTumor02 Phase II Trial

Constellation To Acquire NRG's 44% Stake In South Texas Project Electric Generating Station

AstraZeneca Announces Discontinuation Of IBD Development Programme For Brazikumab

AstraZeneca's Lynparza Gets FDA Approval For BRCAm Prostate Cancer

Sandoz Plans Shift To New Headquarters In Central Basel By Mid-2024

SentinelOne, Inc. Q1 Loss Increases, but beats estimates

Novartis Says Kisqali And Endocrine Therapy Reduces Cancer Recurrence Risk By 25%

Pfizer Says Its Antibiotic Combination Can Help Patients With Life-threatening Bacterial Infections

The Cooper Companies, Inc. Q2 Profit Decreases, but beats estimates

Dollar General Down In Pre-market On Q1 Results, Outlook

Broadcom Limited Q2 Profit Increases, beats estimates

Evotec Gets $1.7 Mln Grant For Discovery Of RNA-targeting Henipavirus Therapeutics

Mortgage Rates Jump Up

NatWest Completes Sale Of EUR 55.2 Mln Of Shares In Permanent TSB

G-III APPAREL GROUP LTD Q1 Profit Decreases, but beats estimates

Dollar General Q1 Results Miss Estimates, Cuts FY23 View; Stock Down In Premarket

Paragon Bank H1 Earnings Fall, But Revenues Rise

Frozen RTE Beef Chili Products Supplied Through NSLP Recalled

Accenture Unit Gets $329 Mln Contract From USAID - Quick Facts

Boeing, NASA Further Delay Starliner Crew Flight Launch

Novartis Says Kisqali And Endocrine Therapy Reduces Cancer Recurrence Risk By 25%

Dollar General Down In Pre-market On Q1 Results, Outlook